N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
Author Information
Author(s): Anuraag Shrivastav, Shailly Varma, Anurag Saxena, John DeCoteau, Rajendra K Sharma
Primary Institution: University of Saskatchewan
Hypothesis
Can N-myristoyltransferase (NMT) serve as a diagnostic marker for colon cancer?
Conclusion
NMT expression and localization differences in blood and bone marrow may help in diagnosing colon cancer.
Supporting Evidence
- NMT activity was higher in the peripheral blood mononuclear cells of tumor-bearing rats compared to controls.
- Strong NMT expression was observed in PBMC of colon cancer patients.
- NMT localization was primarily nuclear in bone marrow cells of tumor-bearing hosts.
Takeaway
This study found that a protein called NMT is more active in people with colon cancer, which could help doctors find cancer without needing surgery.
Methodology
Blood samples were collected from colon cancer patients and control subjects, and NMT activity and expression were analyzed using immunohistochemistry.
Limitations
The study suggests a need for larger sample sizes to validate findings.
Participant Demographics
8 colon cancer patients and 5 control subjects, with a mix of ages and sexes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website